Stifel upgrades biotech stock on a narrative shift in Alzheimer’s treatment
- Posted on November 6, 2025
- By CNBC
- 1 Views
Stifel upgrades biotech stock on a narrative shift in Alzheimer’s treatment
Stifel sees Biogen stock rallying nearly 32% from here.
